Putnam Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-18,795
| Closed | -$1.27M | – | 1259 |
|
|
2017
Q1 | $1.27M | Sell |
18,795
-66,788
| -78% | -$4.53M | ﹤0.01% | 957 |
|
|
2016
Q4 | $6.02M | Sell |
85,583
-442
| -0.5% | -$31.1K | 0.01% | 516 |
|
|
2016
Q3 | $6.1M | Buy |
86,025
+2,936
| +4% | +$208K | 0.01% | 506 |
|
|
2016
Q2 | $4.06M | Buy |
83,089
+18,209
| +28% | +$891K | 0.01% | 719 |
|
|
2016
Q1 | $4.11M | Sell |
64,880
-9,627
| -13% | -$610K | 0.01% | 713 |
|
|
2015
Q4 | $8.36M | Buy |
74,507
+9,627
| +15% | +$1.08M | 0.02% | 507 |
|
|
2015
Q3 | $6.25M | Hold |
64,880
| – | – | 0.01% | 594 |
|
|
2015
Q2 | $6.64M | Buy |
64,880
+200
| +0.3% | +$20.5K | 0.01% | 615 |
|
|
2015
Q1 | $4.02M | Hold |
64,680
| – | – | 0.01% | 840 |
|
|
2014
Q4 | $2.84M | Hold |
64,680
| – | – | 0.01% | 921 |
|
|
2014
Q3 | $3.66M | Sell |
64,680
-200
| -0.3% | -$11.3K | 0.01% | 866 |
|
|
2014
Q2 | $2.91M | Hold |
64,880
| – | – | 0.01% | 937 |
|
|
2014
Q1 | $3.17M | Buy |
+64,880
| New | +$3.17M | 0.01% | 929 |
|